RBC Capital raised the firm’s price target on HCA Healthcare to $405 from $378 and keeps an Outperform rating on the shares after hosting meetings with management this week. HCA management offered clients insight into the strong demand trends seen through the first half of the year and expected through year-end, the opportunity for continued share gains through in-market investment, and the significant opportunity ahead in the near and long term for efficiency gains in AI, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $430 from $390 at Truist
- HCA Healthcare participates in a conference call hosted by Truist
- HCA Healthcare price target raised to $365 from $315 at Wells Fargo
- HCA Healthcare price target raised to $392 from $335 at Cantor Fitzgerald
- HCA Healthcare price target raised to $378 from $329 at RBC Capital